AstraZeneca CFO on AI, Earnings, Restructuring Plan
TL;DR
AstraZeneca Chief Financial Officer Aradhana Sarin says the drug company now uses AI in almost every aspect of its work. In an interview on Bloomberg Surveillance, she discusses the company beating earnings expectations, the state of its drug pipeline and its ongoing restructuring plan. Sarin also explains how AstraZeneca approaches dealmaking as it reshapes the business.
Nauti's Take
If AI runs through almost every step at a drug company, the potential lies mainly in faster research and leaner operations. The catch: a CFO interview says little about how much of that is measurable and how much is investor messaging.
Teams rolling out AI in regulated industries should take note, since proof counts there far more than announcements.
Sources